- NSE
- AJANTPHARM
- BSE
- 532331
- ISIN
- INE031B01049
AJANTA PHARMA
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹3,344.00
+₹36.30 (+1.10%)
NSE close ·
AJANTA PHARMA closed at ₹3,344.00 on 9 Nov 2026, up 1.10% on the day, and is up 32.48% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹2,458.10 to ₹3,718.20.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹41,786 Cr
- P/E (TTM)
- 33.1
- Industry P/E
- 35.5
- EPS (TTM)
- ₹101.00
- P/B
- 8.60
- Book value
- ₹388.79
- ROE
- 25.9%
- ROCE
- 34.3%
- Debt/equity
- 0.02
- Operating margin
- 24.2%
- Net margin
- 20.2%
- Dividend yield
- 0.96%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +25.54% | +16.76% |
| Net profit | +29.70% | +24.13% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹1,832 Cr | ₹388 Cr | +49.18% | ₹31.03 |
| Jun 2026 | ₹1,697 Cr | ₹334 Cr | +30.89% | ₹26.72 |
| Mar 2026 | ₹1,483 Cr | ₹267 Cr | +18.40% | ₹21.34 |
| Dec 2025 | ₹1,400 Cr | ₹274 Cr | +17.56% | ₹21.91 |
| Sep 2025 | ₹1,413 Cr | ₹260 Cr | +20.19% | ₹20.82 |
| Jun 2025 | ₹1,329 Cr | ₹255 Cr | +3.89% | ₹20.43 |
| Mar 2025 | ₹1,189 Cr | ₹225 Cr | +11.12% | ₹18.00 |
| Dec 2024 | ₹1,177 Cr | ₹233 Cr | +10.88% | ₹18.59 |
Armor risk check
AJANTA PHARMA moves about 1.7× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is AJANTA PHARMA's share price today?
AJANTA PHARMA (NSE: AJANTPHARM) closed at ₹3,344.00 on 9 Nov 2026, up 1.10% from the previous close of ₹3,307.70. It traded between ₹3,280.00 and ₹3,410.40 that day.
What are AJANTA PHARMA's 52-week high and low?
Over the last 52 weeks AJANTA PHARMA traded between ₹2,445.80 and ₹3,796.00, adjusted for splits and bonuses.
What are AJANTA PHARMA's NSE symbol, BSE code and ISIN?
AJANTA PHARMA has NSE symbol AJANTPHARM, BSE code 532331, ISIN INE031B01049.
How has AJANTA PHARMA performed over 1, 3 and 5 years?
AJANTA PHARMA's share price return: 1Y +32.48%, 3Y +21.27% a year, 5Y +18.43% a year. Dividends are not included.
Does AJANTA PHARMA pay a dividend?
Yes. AJANTA PHARMA's latest dividend went ex on 5 Aug 2026: Interim · ₹32.00 per share. Dividends over the past year come to a yield of 0.96% at the latest close.
What is AJANTA PHARMA's P/E ratio?
AJANTA PHARMA's P/E ratio is 33.1: the ₹3,344.00 close on 9 Nov 2026 over trailing twelve-month EPS of ₹101.00 (consolidated, four quarters to 30 Sep 2026).
What is AJANTA PHARMA's market cap?
AJANTA PHARMA's market cap is ₹41,786 Cr at the close on 9 Nov 2026.
Which sector is AJANTA PHARMA in?
AJANTA PHARMA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how AJANTA PHARMA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app